COX-2 Inhibition mediated anti-angiogenic activatable prodrug potentiates cancer therapy in preclinical models

201852 citationsJournal Article

Authors

Good health and well-being

Published in: Biomaterials

Volume 185, pp. 63-72

Field-Weighted Citation Impact: 2.38